documents: FDA-2010-N-0621-0145

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2010-N-0621-0145 FDA FDA-2010-N-0621 Appendices List (1-35) - [FDA/CDER, Summary of Arguments Supporting CDER’s Proposal to Withdraw Approval of Avastin’s Indication for the Treatment of Metastatic Breast Cancer - Summary of Agruments] Supporting & Related Material Reference (internal unless indicated) 2011-05-16T04:00:00Z 2011 5     2018-09-10T22:40:02Z   0 0 0900006480c7a7c3

Links from other tables